THE ROLE OF INHIBITORY METABOLITES IN THE P450-BASED DRUG-DRUG INTERACTIONS OF AMIODARONE

被引：0
|
作者：
McDonald, Matthew G. [1 ]
Rettie, Allan E. [1 ]
机构：
[1] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA
来源：
DRUG METABOLISM REVIEWS | 2015年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P198
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [31] Drug-drug interactions of amiodarone on simvastatin metabolism in human liver microsomes
    Wan, C.
    Zhu, N.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 137 : S136 - S136
  • [32] Evaluation of cytochrome P450-mediated drug-drug interactions based on the strategies recommended by regulatory authorities
    Kosugi, Yohei
    Hirabayashi, Hideki
    Igari, Tomoko
    Fujioka, Yasushi
    Hara, Yoko
    Okuda, Teruaki
    Moriwaki, Toshiya
    XENOBIOTICA, 2012, 42 (02) : 127 - 138
  • [33] Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions
    Obach, R. Scott
    Walsky, Robert L.
    Venkatakrishnan, Karthik
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (02) : 246 - 255
  • [34] A new, non-P450-based inhibition attribute of grapefruit juice leading to drug-drug interactions
    Li, Ping
    Callery, Patrick S.
    Gan, Lawrence L.
    Balani, Suresh K.
    DRUG METABOLISM REVIEWS, 2006, 38 : 101 - 101
  • [35] Cytochrome P450 3A and P-glycoprotein drug-drug interactions with voclosporin
    Ling, Spencer Y.
    Huizinga, Robert B.
    Mayo, Patrick R.
    Larouche, Richard
    Freitag, Derrick G.
    Aspeslet, Launa J.
    Foster, Robert T.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (06) : 1039 - 1050
  • [36] Drug-drug interactions with immunosuppressive agents: Review of the in vitro functional assays and role of cytochrome P450 enzymes
    Elbarbry, Fawzy A.
    Marfleet, Travis
    Shoker, Ahmed S.
    TRANSPLANTATION, 2008, 85 (09) : 1222 - 1229
  • [37] PREDICTION OF DRUG-DRUG INTERACTIONS BASED ON CONTRIBUTION OF CYTOCHROME P450 ENZYME TO DRUG METABOLISM USING THE RAF APPROACH IN DRUG DISCOVERY
    Yokoo, Koji
    Tohda, Toshifumi
    Naritomi, Yoichi
    Ueda, Naoki
    Kadono, Keitaro
    Tabata, Kenji
    DRUG METABOLISM REVIEWS, 2015, 47 : 111 - 111
  • [38] Contribution of Metabolites to P450 Inhibition-Based Drug-Drug Interactions: Scholarship from the Drug Metabolism Leadership Group of the Innovation and Quality Consortium Metabolite Group
    Yu, Hongbin
    Balani, Suresh K.
    Chen, Weichao
    Cui, Donghui
    He, Ling
    Humphreys, W. Griffith
    Mao, Jialin
    Lai, W. George
    Lee, Anthony J.
    Lim, Heng-Keang
    MacLauchlin, Christopher
    Prakash, Chandra
    Surapaneni, Sekhar
    Tse, Susanna
    Upthagrove, Alana
    Walsky, Robert L.
    Wen, Bo
    Zeng, Zhaopie
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (04) : 620 - 630
  • [39] Characterization of the In Vitro Inhibitory Potential of the Oligonucleotide Imetelstat on Human Cytochrome P450 Enzymes with Predictions of In Vivo Drug-Drug Interactions
    Kazmi, Faraz
    Sensenhauser, Carlo
    Greway, Tony
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (01) : 9 - 14
  • [40] The mechanisms of interactions of psychotropic drugs with liver and brain cytochrome P450 and their significance for drug effect and drug-drug interactions
    Daniel, Wladyslawa A.
    Bromek, Ewa
    Danek, Przemyslaw J.
    Haduch, Anna
    BIOCHEMICAL PHARMACOLOGY, 2022, 199
12345